HPQ Silica Pharmaceutical is a Canadian company that specializes in the production and commercialization of pure silica, a mineral used in a variety of applications, including the pharmaceutical industry. Silica is a natural mineral that is found in abundance in rocks and soils, and is a key ingredient in many products, including glass, ceramics, and electronics.
Silica has been used in the pharmaceutical industry for many years due to its unique properties, such as its high surface area and adsorption capacity. It is commonly used as a carrier for drugs and as a stabilizer for proteins and other biomolecules. In addition, silica has been shown to have biocompatible and biodegradable properties, making it a safe and effective material for use in pharmaceutical applications.
Click on the link for sample report: https://www.persistencemarketresearch.com/samples/25132
HPQ Silica Pharmaceutical has developed a proprietary process for producing high-purity silica using a low-cost and environmentally friendly process. This process, called PUREVAPTM, uses a plasma-based technology to purify raw silica to a level of 99.9% purity. This high-purity silica can then be used in a variety of pharmaceutical applications, including drug delivery, medical implants, and tissue engineering.
One of the key advantages of HPQ Silica Pharmaceutical’s PUREVAPTM process is that it is scalable and can be used to produce silica at a large scale. This is important because the demand for high-purity silica in the pharmaceutical industry is growing rapidly, driven by the increasing use of biologics and other complex drugs that require specialized delivery systems.
In addition to its pharmaceutical applications, high-purity silica has a wide range of other uses, including in the production of semiconductors, solar panels, and other high-tech applications. This means that HPQ Silica Pharmaceutical’s technology has the potential to be used in a variety of industries, making it a versatile and valuable material.
Overall, HPQ Silica Pharmaceutical is a company with a promising future, thanks to its innovative technology and the growing demand for high-purity silica in the pharmaceutical and other industries. As the company continues to develop and commercialize its technology, it has the potential to become a leading supplier of pure silica to these industries and to play a key role in advancing the field of biotechnology and medicine.
About us:
The Chemicals and Materials division of Persistence Market Research offers distinct and pin-point analysis about chemicals and materials industry. Chemical coverage extends from commodity, bulk, specialty and petrochemicals to advanced materials, composites and nanotechnology in particular with special emphasis on ‘green alternatives’, recycling and renewable technology developments, supply-demand-trade assessment. Our research studies are widely referred by chemical manufacturers, research institutions, channel partners and government bodies for developing – ‘The Way Forward’.
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353